Cargando…
Is COPD a Progressive Disease? A Long Term Bode Cohort Observation
BACKGROUND: The Global Initiative for Obstructive Lung Diseases (GOLD) defines COPD as a disease that is usually progressive. GOLD also provides a spirometric classification of airflow limitation. However, little is known about the long-term changes of patients in different GOLD grades. OBJECTIVE: E...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839642/ https://www.ncbi.nlm.nih.gov/pubmed/27100872 http://dx.doi.org/10.1371/journal.pone.0151856 |
_version_ | 1782428154986496000 |
---|---|
author | de-Torres, Juan P. Marín, Jose M. Pinto-Plata, Víctor Divo, Miguel Sanchez-Salcedo, Pablo Zagaceta, Jorge Zulueta, Javier J. Berto, Juan Cabrera, Carlos Celli, Bartolome R. Casanova, Ciro |
author_facet | de-Torres, Juan P. Marín, Jose M. Pinto-Plata, Víctor Divo, Miguel Sanchez-Salcedo, Pablo Zagaceta, Jorge Zulueta, Javier J. Berto, Juan Cabrera, Carlos Celli, Bartolome R. Casanova, Ciro |
author_sort | de-Torres, Juan P. |
collection | PubMed |
description | BACKGROUND: The Global Initiative for Obstructive Lung Diseases (GOLD) defines COPD as a disease that is usually progressive. GOLD also provides a spirometric classification of airflow limitation. However, little is known about the long-term changes of patients in different GOLD grades. OBJECTIVE: Explore the proportion and characteristics of COPD patients that change their spirometric GOLD grade over long-term follow-up. METHODS: Patients alive for at least 8 years since recruitment and those who died with at least 4 years of repeated spirometric measurements were selected from the BODE cohort database. We purposely included the group of non survivors to avoid a “survival selection” bias. The proportion of patients that had a change (improvement or worsening) in their spirometric GOLD grading was calculated and their characteristics compared with those that remained in the same grade. RESULTS: A total of 318 patients were included in the survivor and 217 in the non-survivor groups. Nine percent of survivors and 11% of non survivors had an improvement of at least one GOLD grade. Seventy one percent of survivors and non-survivors remained in the same GOLD grade. Those that improved had a greater degree of airway obstruction at baseline. CONCLUSIONS: In this selected population of COPD patients, a high proportion of patients remained in the same spirometric GOLD grade or improved in a long-term follow-up. These findings suggest that once diagnosed, COPD is usually a non-progressive disease. |
format | Online Article Text |
id | pubmed-4839642 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-48396422016-04-29 Is COPD a Progressive Disease? A Long Term Bode Cohort Observation de-Torres, Juan P. Marín, Jose M. Pinto-Plata, Víctor Divo, Miguel Sanchez-Salcedo, Pablo Zagaceta, Jorge Zulueta, Javier J. Berto, Juan Cabrera, Carlos Celli, Bartolome R. Casanova, Ciro PLoS One Research Article BACKGROUND: The Global Initiative for Obstructive Lung Diseases (GOLD) defines COPD as a disease that is usually progressive. GOLD also provides a spirometric classification of airflow limitation. However, little is known about the long-term changes of patients in different GOLD grades. OBJECTIVE: Explore the proportion and characteristics of COPD patients that change their spirometric GOLD grade over long-term follow-up. METHODS: Patients alive for at least 8 years since recruitment and those who died with at least 4 years of repeated spirometric measurements were selected from the BODE cohort database. We purposely included the group of non survivors to avoid a “survival selection” bias. The proportion of patients that had a change (improvement or worsening) in their spirometric GOLD grading was calculated and their characteristics compared with those that remained in the same grade. RESULTS: A total of 318 patients were included in the survivor and 217 in the non-survivor groups. Nine percent of survivors and 11% of non survivors had an improvement of at least one GOLD grade. Seventy one percent of survivors and non-survivors remained in the same GOLD grade. Those that improved had a greater degree of airway obstruction at baseline. CONCLUSIONS: In this selected population of COPD patients, a high proportion of patients remained in the same spirometric GOLD grade or improved in a long-term follow-up. These findings suggest that once diagnosed, COPD is usually a non-progressive disease. Public Library of Science 2016-04-21 /pmc/articles/PMC4839642/ /pubmed/27100872 http://dx.doi.org/10.1371/journal.pone.0151856 Text en © 2016 de-Torres et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article de-Torres, Juan P. Marín, Jose M. Pinto-Plata, Víctor Divo, Miguel Sanchez-Salcedo, Pablo Zagaceta, Jorge Zulueta, Javier J. Berto, Juan Cabrera, Carlos Celli, Bartolome R. Casanova, Ciro Is COPD a Progressive Disease? A Long Term Bode Cohort Observation |
title | Is COPD a Progressive Disease? A Long Term Bode Cohort Observation |
title_full | Is COPD a Progressive Disease? A Long Term Bode Cohort Observation |
title_fullStr | Is COPD a Progressive Disease? A Long Term Bode Cohort Observation |
title_full_unstemmed | Is COPD a Progressive Disease? A Long Term Bode Cohort Observation |
title_short | Is COPD a Progressive Disease? A Long Term Bode Cohort Observation |
title_sort | is copd a progressive disease? a long term bode cohort observation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839642/ https://www.ncbi.nlm.nih.gov/pubmed/27100872 http://dx.doi.org/10.1371/journal.pone.0151856 |
work_keys_str_mv | AT detorresjuanp iscopdaprogressivediseasealongtermbodecohortobservation AT marinjosem iscopdaprogressivediseasealongtermbodecohortobservation AT pintoplatavictor iscopdaprogressivediseasealongtermbodecohortobservation AT divomiguel iscopdaprogressivediseasealongtermbodecohortobservation AT sanchezsalcedopablo iscopdaprogressivediseasealongtermbodecohortobservation AT zagacetajorge iscopdaprogressivediseasealongtermbodecohortobservation AT zuluetajavierj iscopdaprogressivediseasealongtermbodecohortobservation AT bertojuan iscopdaprogressivediseasealongtermbodecohortobservation AT cabreracarlos iscopdaprogressivediseasealongtermbodecohortobservation AT cellibartolomer iscopdaprogressivediseasealongtermbodecohortobservation AT casanovaciro iscopdaprogressivediseasealongtermbodecohortobservation |